DILATED CARDIOMYOPATHY MARKET ANALYSIS

Market News

Key Developments:

• In August 2019, MyoKardia, Inc., launched the 2^nd Annual Myoseeds Research Grant Program in order to promote independent research in biology and to understand the mechanism of cardiomyopathies and its treatment.
• In 2019, the DCM Foundation in Ohio, announced the launch of a website to increase awareness for dilated cardiomyopathy (DCM) and to educate the patients and their loved ones on the for the management of the heart condition. Many causes of DCM have been reported and approximately 1 in 250 people have DCM. Many patients have been reported to suffer from Idiopathic DCM, meaning, DCM due to unknown cause. Hence, genetic factors are considered to play a key role in idiopathic DCM, hence, in order to find this relation, DCM foundation has collaborated with DCM Research Project which is funded by National Institute of Health. The findings are always published on the DCM website.
• In 2018, Myokardia, Inc., collaborated with 23andMe, a DNA testing and Analysis Company located in California, in order to conduct advanced research for the patients suffering from Hypertrophic Myopathy (HCM) and DCM, to improve the quality of life of the patients as well as to provide effective treatment to the patients.
• In 2017, Phosphorus, Inc., launched advanced genetic tests for the diagnosis of DCM due to the inherited conditions which are associated with early-onset of the cardiovascular disease and sudden death.